Contrive Datum Insights has published "Cannabis Market Size, Share & Industry Analysis, By Source (Marijuana, Flowers, Oil and Tinctures, Hemp, Hemp CBD, Supplements, Industrial Hemp), Derivative (THC, CBD, Others), End-use (Medical Use, Cancer, Chronic Pain), Depression and anxiety (Recreational Use, Industrial Use, Epilepsy, Multiple Sclerosis, Arthritis, Post-Traumatic Stress Disorder (PTSD), Migraines, Glaucoma, Parkinson's, Diabetes, Alzheimer's, AIDS, Amyotrophic Lateral Sclerosis, Tourette's), Distribution channel (Dispensaries and Retail Stores, Pharmacies, Online and E-commerce), and Regional Forecast, 2026-2034". The study sizes the global cannabis market at USD 68 billion in 2025 and projects growth from USD 77.5 billion in 2026 to USD 194.3 billion by 2034, a compound annual growth rate of 12.18% across the forecast period.
The cannabis market covers legally cultivated and processed cannabis and hemp-derived products sold for medical, wellness and adult recreational use, spanning raw flower, oils, tinctures, concentrates, edibles, topicals and hemp-derived CBD formulations. Buyers range from licensed dispensaries, pharmacies and specialty retailers to individual medical patients under physician-supervised programs and adult consumers in jurisdictions permitting recreational sale. It excludes cannabis grown or sold outside a jurisdiction's licensed legal framework.
Expanding adult-use legalization across new state and national markets
Expanding adult-use legalization across new state and national markets is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 12.18% a year, the source lines exposed to it move fastest: Industrial Hemp compounds at 15.77%, taking its share of revenue from 3% to 4% and its value from USD 2.04 billion to USD 7.77 billion.
On the upside, the study's bull case assumes bull assumes faster-than-scheduled legalization in additional U.S. states and at least one major EU market beyond Germany, plus continued double-digit growth in CBD wellness retail without a price-compression correction, which would take 2034 revenue to USD 223.45 billion rather than the USD 194.3 billion base case.
However, bear assumes U.S. federal reform stalls beyond 2028, cultivation oversupply extends price compression further into the forecast period, and at least one currently-legal European medical market tightens its licensing framework, which would hold 2034 revenue to USD 169.04 billion. Marijuana, which carries 34% of 2025 revenue, already grows at only 11.01% against the market's 12.18%, so the largest part of the base is also its slowest.
Key Players Compete on Marijuana Volume and Industrial Hemp Growth
Competition in the global cannabis market runs along the source axis rather than the regional one. Marijuana holds 34% of 2025 revenue at USD 23.12 billion and remains the largest line through 2034 at 31%, making it the position hardest for a challenger to take. Industrial Hemp, growing at 15.77%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 68 billion.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Source | Marijuana | 34% · USD 23.12 billion | — |
| Derivative | THC | 58% · USD 39.44 billion | Others 14.68% |
| End-use | Medical Use | 55% · USD 37.4 billion | Chronic Pain 13.8% |
| Depression and anxiety | Recreational Use | 44% · USD 29.92 billion | Industrial Use 15.2% |
| Distribution channel | Dispensaries and Retail Stores | 68% · USD 46.24 billion | Online and E-commerce 17.25% |
- Based on regional analysis, North America led the global cannabis market in 2025 with 62% of global revenue at USD 42.16 billion, reaching USD 106.87 billion by 2034.
- Europe takes a rising share of global revenue over the forecast period, from 20% in 2025 to 24% in 2034, with revenue growing from USD 13.6 billion to USD 46.63 billion.
- Middle East and Africa remains the smallest region throughout, at 3% of 2025 revenue and 3% by 2034.
- Industrial Hemp is projected to grow at 15.77% over the forecast period, the fastest of any source line.
- The United States is the largest single country market at USD 34.99 billion in 2025, 51.46% of global revenue.
The report segments the market across five axes; by source, and by derivative, end-use, depression and anxiety and distribution channel; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 169.04 billion and USD 223.45 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.